Cargando…
Lessons learned from the COVID pandemic and its impact on bioanalysis and drug development
The COVID-19 pandemic challenged pharmaceutical and bioanalytical communities at large, in the development of vaccines and therapeutics as well as supporting ongoing drug development efforts. Existing processes were challenged to manage loss of staffing at facilities along with added workloads for C...
Autores principales: | Wickremsinhe, Enaksha R, Brockus, Catherine L, Murphy, Anthony T |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Newlands Press Ltd
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8288281/ https://www.ncbi.nlm.nih.gov/pubmed/34275332 http://dx.doi.org/10.4155/bio-2021-0120 |
Ejemplares similares
-
How the COVID-19 pandemic is changing clinical trial conduct and driving innovation in bioanalysis
por: Anderson, Melanie
Publicado: (2021) -
Bioanalysis in drug discovery and development
por: Pandey, Saurabh, et al.
Publicado: (2010) -
Leveraging lessons learned from the COVID-19 pandemic for HIV
por: Calder, Thomas, et al.
Publicado: (2022) -
Bioanalysis in the Age of New Drug Modalities
por: Shi, Jing, et al.
Publicado: (2021) -
PCR in bioanalysis /
Publicado: (1998)